HIV-ASSOCIATED NEUROCOGNITIVE DISORDERS: DIAGNOSIS, DETECTION OF CAUSES AND THERAPY EFFICIENCY
-
Published:2019-01-16
Issue:4
Volume:10
Page:7-24
-
ISSN:2077-9828
-
Container-title:HIV Infection and Immunosuppressive Disorders
-
language:
-
Short-container-title:VIČ-infekc. immunosupr.
Author:
Trofimova T. N.1, Katayeva G. V.2, Gromova E. A.2, Rassokhin V. V.3, Boeva E. V.4, Simakina O. E.5, Belyakov N. A.3
Affiliation:
1. V.M.Bekhterev National Medical Research Center of Psychiatry and Neurology; FSBSI «IEM»; FSBSI HE I.P.Pavlov SPbSMU MON Russia 2. V.M.Bekhterev National Medical Research Center of Psychiatry and Neurology 3. FSBSI «IEM»; FSBSI HE I.P.Pavlov SPbSMU MON Russia; Saint-Petersburg Pasteur Institute 4. FSBSI HE I.P.Pavlov SPbSMU MON Russia; Saint-Petersburg Pasteur Institute; Leningrad regional Center for prevention and control of AIDS and infectious diseases 5. FSBSI «IEM»
Abstract
The lecture intended for general practitioners represents collated information on the most important mechanisms of brain damage under HIV infection, the rate of neurocognitive disorders and their role in disability of patients, classification of these disorders. The capabilities and importance of diagnosis and an in-depth work-up of patients for establishing complete clinical diagnosis and order of effective treatment are presented in the lecture. Much attention is given to immunosuppression influence, brain cell elements involvement and forming of reservoir of HIV infection in pathogenesis of neurocognitive diseases. The lecture describes special aspects of radiology examinations including magnetic resonance imaging, magnetic resonance spectroscopy for assessment of metabolism and tissue perfusion using some chemical markers. Approaches to prevention, diagnosis and treatment are provided taking into account the stage of a disease. An algorithm of detection of causes and diagnosis of cognitive disorders is stated in the lecture and the role of different diagnostic approaches at different stages of HIV infection including HIV-associated diseases is shown.
Publisher
Baltic Medical Education Center
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Immunology
Reference65 articles.
1. Grant I., Atkinson J.H., Hesselink J.R., Kennedy C.J., Richman D.D., Spector S.A., McCutchan J.A. Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann. Intern. Med., 1987, Vol. 107, No. 6, pp. 828–836. 2. Antinori A., Arendt G., Becker J.T., Brew B.J., Byrd D.A., Cherner M., Clifford D.B., Cinque P., Epstein L.G., Goodkin K., Gisslen M., Grant I., Heaton R.K., Joseph J., Marder K., Marra C.M., McArthur J.C., Nunn M., Price R.W., Pulliam L., Robertson K.R., Sacktor N., Valcour V., Wojna V.E. Updated research nosology for HIV-associated neurocognitive disorders. J. Neurol., 2007, Vol. 69, No. 18, pp. 1789–1799. 3. Heaton R.K., Franklin D.R., Ellis R.J., McCutchan J.A., Letendre S.L., Leblanc S., Corkran S.H., Duarte N.A., Clifford D.B., Woods S.P., Collier A.C., Marra C.M., Morgello S., Mindt M.R., Taylor M.J., Marcotte T.D., Atkinson J.H., Wolfson T., Gelman B.B., McArthur J.C., Simpson D.M., Abramson I., Gamst A., Fennema-Notestine C., Jernigan T.L., Wong J., Grant I.; CHARTER Group; HNRC Group. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J. Neurovirol., 2011, Vol. 17, No. 1, pp. 3–16. 4. Ellis R.J., Badiee J., Vaida F., Letendre S., Heaton R.K., Clifford D., Collier A.C., Gelman B., McArthur J., Morgello S., McCutchan J.A., Grant I; CHARTER Group. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS, 2011, Vol. 25, No. 14, pp. 1747–1751. 5. Weber E., Morgan E.E., Iudicello J.E., Blackstone K., Grant I., Ellis R.J., Letendre S.L., Little S., Morris S., Smith D.M., Moore D.J., Woods S.P.; TMARC Group. Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection. J. Neurovirol., 2013, Vol. 19, No. 1, pp. 65–74. URL: DOI: 10.1007/s13365-012-0141-y (Epub. 2012, Dec. 19).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|